Pilot Trial of Intravenous DP-b99 in the Treatment of First-ever Episode of Non-obstructive Acute High-risk Pancreatitis
Phase of Trial: Phase II
Latest Information Update: 30 Jul 2015
Price : $35 *
At a glance
- Drugs DP b99 (Primary)
- Indications Pancreatitis
- Focus Pharmacodynamics
- Sponsors D-Pharm
- 31 Aug 2018 Biomarkers information updated
- 30 Jul 2015 Final results published in D-Pharm media release.
- 22 Jun 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.